You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪安診斷(300244.SZ):募投項目擬延期、變更、終止並永久補流
格隆匯 11-30 20:20

格隆匯11月30日丨迪安診斷(300244.SZ)公佈,2021年11月30日,公司第四屆董事會第十四次會議、第四屆監事會第九次會議審議通過了《關於募集資金投資項目延期、變更、終止並永久補流的議案》。為提高募集資金使用效率,匹配現階段經營發展的實際需要以創造更大的效益價值,公司擬對募集資金投資項目進行如下調整:

1、“杭州診斷業務平台服務能力提升及研發項目”(“杭州項目”,即項目一“診斷業務平台服務能力提升及研發項目”的子項目)以及項目三“醫療診斷數據存儲分析應用平台技術開發及設備改造項目”實施期限延長至2023年12月31日;

2、其餘募集資金投資項目終止,尚未使用的募集資金合計47838.21萬元(不含利息收益為46,836.50萬元),其中4641.66萬元用於新項目“北京迪安醫學檢驗實驗室診斷業務平台能力提升項目”,剩餘募集資金43196.55萬元(不含利息收益42194.84萬元)全部用於永久性補充流動資金(具體金額以募投賬户內的含利息淨收益的實際資金為準,下同)。

根據《深圳證券交易所創業板股票上市規則》、《深圳證券交易所創業板上市公司規範運作指引》等有關規定,該事項尚須提交公司股東大會審議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account